Neximmune Stock Price Prediction
| NEXI Stock | USD 3.28 0.09 2.67% |
Oversold Vs Overbought
25
Oversold | Overbought |
Neximmune stock price prediction is an act of determining the future value of Neximmune shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Neximmune's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Neximmune and does not consider all of the tangible or intangible factors available from Neximmune's fundamental data. We analyze noise-free headlines and recent hype associated with Neximmune, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Neximmune's stock price prediction:Wall Street Target Price 2 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Neximmune based on different types of headlines from major news networks to social media. The Neximmune stock price prediction module provides an analysis of price elasticity to changes in media outlook on Neximmune over a specific investment horizon. Using Neximmune hype-based prediction, you can estimate the value of Neximmune from the perspective of Neximmune response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Neximmune. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Neximmune to buy its stock at a price that has no basis in reality. In that case, they are not buying Neximmune because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Neximmune after-hype prediction price | USD 3.6 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Neximmune |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neximmune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neximmune After-Hype Price Prediction Density Analysis
As far as predicting the price of Neximmune at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Neximmune or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Neximmune, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Neximmune Estimiated After-Hype Price Volatility
In the context of predicting Neximmune's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Neximmune's historical news coverage. Neximmune's after-hype downside and upside margins for the prediction period are 0.18 and 10.26, respectively. We have considered Neximmune's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Neximmune is dangerous at this time. Analysis and calculation of next after-hype price of Neximmune is based on 3 months time horizon.
Neximmune Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Neximmune is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Neximmune backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Neximmune, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
2.16 | 6.66 | 0.32 | 1.38 | 7 Events / Month | 14 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.28 | 3.60 | 9.76 |
|
Neximmune Hype Timeline
Neximmune is now traded for 3.28. The entity has historical hype elasticity of 0.32, and average elasticity to hype of competition of 1.38. Neximmune is anticipated to increase in value after the next headline, with the price projected to jump to 3.6 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 9.76%, whereas the daily expected return is now at -2.16%. The volatility of related hype on Neximmune is about 1043.07%, with the expected price after the next announcement by competition of 4.66. The company has return on total asset (ROA) of (0.7062) % which means that it has lost $0.7062 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.8064) %, meaning that it created substantial loss on money invested by shareholders. Neximmune's management efficiency ratios could be used to measure how well Neximmune manages its routine affairs as well as how well it operates its assets and liabilities. The Neximmune's current Return On Tangible Assets is estimated to increase to -3.58. The Neximmune's current Return On Capital Employed is estimated to increase to -7.9. As of now, Neximmune's Other Assets are increasing as compared to previous years. Given the investment horizon of 90 days the next anticipated press release will be in about 7 days. Check out Neximmune Basic Forecasting Models to cross-verify your projections.Neximmune Related Hype Analysis
Having access to credible news sources related to Neximmune's direct competition is more important than ever and may enhance your ability to predict Neximmune's future price movements. Getting to know how Neximmune's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Neximmune may potentially react to the hype associated with one of its peers.
Neximmune Additional Predictive Modules
Most predictive techniques to examine Neximmune price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Neximmune using various technical indicators. When you analyze Neximmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neximmune Predictive Indicators
The successful prediction of Neximmune stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Neximmune, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Neximmune based on analysis of Neximmune hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Neximmune's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Neximmune's related companies. Story Coverage note for Neximmune
The number of cover stories for Neximmune depends on current market conditions and Neximmune's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Neximmune is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Neximmune's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Neximmune Short Properties
Neximmune's future price predictability will typically decrease when Neximmune's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Neximmune often depends not only on the future outlook of the potential Neximmune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neximmune's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 4.6 M |
Check out Neximmune Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Neximmune Stock please use our How to Invest in Neximmune guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Neximmune Stock analysis
When running Neximmune's price analysis, check to measure Neximmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neximmune is operating at the current time. Most of Neximmune's value examination focuses on studying past and present price action to predict the probability of Neximmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neximmune's price. Additionally, you may evaluate how the addition of Neximmune to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Neximmune's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neximmune. If investors know Neximmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neximmune listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (30.82) | Return On Assets (0.71) | Return On Equity (1.81) |
The market value of Neximmune is measured differently than its book value, which is the value of Neximmune that is recorded on the company's balance sheet. Investors also form their own opinion of Neximmune's value that differs from its market value or its book value, called intrinsic value, which is Neximmune's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neximmune's market value can be influenced by many factors that don't directly affect Neximmune's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neximmune's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neximmune is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neximmune's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.